Tequesta Research Group Tequesta Research Group

Capabilities

We think Family Medicine/Internal Medicine when looking for new studies. Uniquely, we draw upon an approximately 5,000 patient-base, all of which come from our Principal Investigator's, and our Sub-Investigator's practices.

Hyperlipidemia, Type 2 diabetes, cardiovascular disease, osteoarthritis, gastrointestinal disorders are some of the diseases strongly represented in a practice which spans ages from 20's to 80's.

Phases

We concentrate, primarily, on PHASES 2 THROUGH 4.

Diagnoses

Some of our recent studies include:
  • Cardiovascular disease in the African-American population
  • Two phase 3 studies in patients with hyperlipidemia
  • A phase 3 study pertaining to the efficacy of a compound to be used in the treatment of C. difficile
  • Two phase 4 studies in patients with osteoarthritis, which provide data on the long-term effects on cardiac health and the gastrointestinal system
  • A study of type 2 diabetics who are poorly controlled on metformin, using add-on therapy of either Avandia or Actos
Tequesta Research Group | 3301 SW 34th Circle | Suites 301 & 302 | Ocala, FL 34474
© Tequesta Research Group TR All rights reserved. Website by PS Design PS Design LLC
info@tequestaresearch.com | P. 352-620-2413 | F. 352-629-0587
Home | Medical Practice | Contact | Sitemap